nodes	percent_of_prediction	percent_of_DWPC	metapath
Pomalidomide—TNF—type 1 diabetes mellitus	0.818	1	CbGaD
Pomalidomide—Thalidomide—TNF—type 1 diabetes mellitus	0.00296	1	CrCbGaD
Pomalidomide—White blood cell count decreased—Ramipril—type 1 diabetes mellitus	0.00286	0.0847	CcSEcCtD
Pomalidomide—Neuropathy—Ramipril—type 1 diabetes mellitus	0.00134	0.0396	CcSEcCtD
Pomalidomide—Atrial fibrillation—Ramipril—type 1 diabetes mellitus	0.00109	0.0323	CcSEcCtD
Pomalidomide—Hyponatraemia—Ramipril—type 1 diabetes mellitus	0.00104	0.0307	CcSEcCtD
Pomalidomide—Blood creatinine increased—Ramipril—type 1 diabetes mellitus	0.000968	0.0287	CcSEcCtD
Pomalidomide—Breast disorder—Ramipril—type 1 diabetes mellitus	0.000934	0.0276	CcSEcCtD
Pomalidomide—Bronchitis—Ramipril—type 1 diabetes mellitus	0.000859	0.0254	CcSEcCtD
Pomalidomide—Pancytopenia—Ramipril—type 1 diabetes mellitus	0.000848	0.0251	CcSEcCtD
Pomalidomide—Neutropenia—Ramipril—type 1 diabetes mellitus	0.000835	0.0247	CcSEcCtD
Pomalidomide—Upper respiratory tract infection—Ramipril—type 1 diabetes mellitus	0.00083	0.0246	CcSEcCtD
Pomalidomide—Weight increased—Ramipril—type 1 diabetes mellitus	0.000813	0.0241	CcSEcCtD
Pomalidomide—Renal failure—Ramipril—type 1 diabetes mellitus	0.000783	0.0232	CcSEcCtD
Pomalidomide—Neuropathy peripheral—Ramipril—type 1 diabetes mellitus	0.00078	0.0231	CcSEcCtD
Pomalidomide—Urinary tract infection—Ramipril—type 1 diabetes mellitus	0.000774	0.0229	CcSEcCtD
Pomalidomide—Hepatobiliary disease—Ramipril—type 1 diabetes mellitus	0.000753	0.0223	CcSEcCtD
Pomalidomide—Epistaxis—Ramipril—type 1 diabetes mellitus	0.000751	0.0222	CcSEcCtD
Pomalidomide—Oedema peripheral—Ramipril—type 1 diabetes mellitus	0.000704	0.0208	CcSEcCtD
Pomalidomide—Connective tissue disorder—Ramipril—type 1 diabetes mellitus	0.000702	0.0208	CcSEcCtD
Pomalidomide—Mediastinal disorder—Ramipril—type 1 diabetes mellitus	0.000644	0.0191	CcSEcCtD
Pomalidomide—Mental disorder—Ramipril—type 1 diabetes mellitus	0.000626	0.0185	CcSEcCtD
Pomalidomide—Malnutrition—Ramipril—type 1 diabetes mellitus	0.000622	0.0184	CcSEcCtD
Pomalidomide—Muscle spasms—Ramipril—type 1 diabetes mellitus	0.000598	0.0177	CcSEcCtD
Pomalidomide—Tremor—Ramipril—type 1 diabetes mellitus	0.000583	0.0173	CcSEcCtD
Pomalidomide—Vertigo—Ramipril—type 1 diabetes mellitus	0.000559	0.0166	CcSEcCtD
Pomalidomide—Leukopenia—Ramipril—type 1 diabetes mellitus	0.000557	0.0165	CcSEcCtD
Pomalidomide—Cough—Ramipril—type 1 diabetes mellitus	0.000543	0.0161	CcSEcCtD
Pomalidomide—Arthralgia—Ramipril—type 1 diabetes mellitus	0.00053	0.0157	CcSEcCtD
Pomalidomide—Anxiety—Ramipril—type 1 diabetes mellitus	0.000528	0.0156	CcSEcCtD
Pomalidomide—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 1 diabetes mellitus	0.000526	0.0156	CcSEcCtD
Pomalidomide—Confusional state—Ramipril—type 1 diabetes mellitus	0.000512	0.0152	CcSEcCtD
Pomalidomide—Nervous system disorder—Ramipril—type 1 diabetes mellitus	0.000498	0.0147	CcSEcCtD
Pomalidomide—Thrombocytopenia—Ramipril—type 1 diabetes mellitus	0.000497	0.0147	CcSEcCtD
Pomalidomide—Skin disorder—Ramipril—type 1 diabetes mellitus	0.000493	0.0146	CcSEcCtD
Pomalidomide—Hyperhidrosis—Ramipril—type 1 diabetes mellitus	0.000491	0.0145	CcSEcCtD
Pomalidomide—Musculoskeletal discomfort—Ramipril—type 1 diabetes mellitus	0.000463	0.0137	CcSEcCtD
Pomalidomide—Insomnia—Ramipril—type 1 diabetes mellitus	0.000459	0.0136	CcSEcCtD
Pomalidomide—Dyspnoea—Ramipril—type 1 diabetes mellitus	0.000453	0.0134	CcSEcCtD
Pomalidomide—Decreased appetite—Ramipril—type 1 diabetes mellitus	0.000441	0.0131	CcSEcCtD
Pomalidomide—Gastrointestinal disorder—Ramipril—type 1 diabetes mellitus	0.000438	0.013	CcSEcCtD
Pomalidomide—Fatigue—Ramipril—type 1 diabetes mellitus	0.000438	0.013	CcSEcCtD
Pomalidomide—Constipation—Ramipril—type 1 diabetes mellitus	0.000434	0.0129	CcSEcCtD
Pomalidomide—Feeling abnormal—Ramipril—type 1 diabetes mellitus	0.000418	0.0124	CcSEcCtD
Pomalidomide—Body temperature increased—Ramipril—type 1 diabetes mellitus	0.000401	0.0119	CcSEcCtD
Pomalidomide—Hypersensitivity—Ramipril—type 1 diabetes mellitus	0.000374	0.0111	CcSEcCtD
Pomalidomide—Asthenia—Ramipril—type 1 diabetes mellitus	0.000364	0.0108	CcSEcCtD
Pomalidomide—Pruritus—Ramipril—type 1 diabetes mellitus	0.000359	0.0106	CcSEcCtD
Pomalidomide—Diarrhoea—Ramipril—type 1 diabetes mellitus	0.000347	0.0103	CcSEcCtD
Pomalidomide—Dizziness—Ramipril—type 1 diabetes mellitus	0.000336	0.00994	CcSEcCtD
Pomalidomide—Vomiting—Ramipril—type 1 diabetes mellitus	0.000323	0.00956	CcSEcCtD
Pomalidomide—Rash—Ramipril—type 1 diabetes mellitus	0.00032	0.00948	CcSEcCtD
Pomalidomide—Dermatitis—Ramipril—type 1 diabetes mellitus	0.00032	0.00947	CcSEcCtD
Pomalidomide—Headache—Ramipril—type 1 diabetes mellitus	0.000318	0.00942	CcSEcCtD
Pomalidomide—Nausea—Ramipril—type 1 diabetes mellitus	0.000302	0.00893	CcSEcCtD
Pomalidomide—TNF—Spinal Cord Injury—E2F1—type 1 diabetes mellitus	0.000257	0.00176	CbGpPWpGaD
Pomalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—CASP12—type 1 diabetes mellitus	0.000249	0.00171	CbGpPWpGaD
Pomalidomide—TNF—Caspase Cascade in Apoptosis—CASP3—type 1 diabetes mellitus	0.000249	0.0017	CbGpPWpGaD
Pomalidomide—TNF—Folate Metabolism—IFNG—type 1 diabetes mellitus	0.000248	0.0017	CbGpPWpGaD
Pomalidomide—TNF—Downstream signaling in naïve CD8+ T cells—IFNG—type 1 diabetes mellitus	0.000248	0.0017	CbGpPWpGaD
Pomalidomide—CYP1A2—Estrogen Receptor Pathway—STAT3—type 1 diabetes mellitus	0.000238	0.00164	CbGpPWpGaD
Pomalidomide—TNF—Adipogenesis—E2F1—type 1 diabetes mellitus	0.000238	0.00163	CbGpPWpGaD
Pomalidomide—TNF—Regulation of toll-like receptor signaling pathway—CD86—type 1 diabetes mellitus	0.000237	0.00163	CbGpPWpGaD
Pomalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—IL1R1—type 1 diabetes mellitus	0.000237	0.00162	CbGpPWpGaD
Pomalidomide—TNF—Apoptosis—IGF1—type 1 diabetes mellitus	0.000237	0.00162	CbGpPWpGaD
Pomalidomide—TNF—MicroRNAs in cardiomyocyte hypertrophy—IGF1—type 1 diabetes mellitus	0.000237	0.00162	CbGpPWpGaD
Pomalidomide—TNF—Selenium Micronutrient Network—INS—type 1 diabetes mellitus	0.000236	0.00162	CbGpPWpGaD
Pomalidomide—TNF—amb2 Integrin signaling—IL6—type 1 diabetes mellitus	0.000231	0.00159	CbGpPWpGaD
Pomalidomide—TNF—Developmental Biology—PDX1—type 1 diabetes mellitus	0.000225	0.00155	CbGpPWpGaD
Pomalidomide—TNF—Developmental Biology—HNF1A—type 1 diabetes mellitus	0.000225	0.00155	CbGpPWpGaD
Pomalidomide—TNF—Aryl Hydrocarbon Receptor—EGFR—type 1 diabetes mellitus	0.000225	0.00155	CbGpPWpGaD
Pomalidomide—TNF—Aryl Hydrocarbon Receptor Pathway—EGFR—type 1 diabetes mellitus	0.000225	0.00155	CbGpPWpGaD
Pomalidomide—TNF—Toll-like Receptor Signaling Pathway—CD80—type 1 diabetes mellitus	0.000222	0.00152	CbGpPWpGaD
Pomalidomide—TNF—Folate Metabolism—IL1B—type 1 diabetes mellitus	0.000222	0.00152	CbGpPWpGaD
Pomalidomide—TNF—Folate Metabolism—IL2—type 1 diabetes mellitus	0.000221	0.00151	CbGpPWpGaD
Pomalidomide—TNF—Downstream signaling in naïve CD8+ T cells—IL2—type 1 diabetes mellitus	0.000221	0.00151	CbGpPWpGaD
Pomalidomide—PTGS2—Selenium Micronutrient Network—CAT—type 1 diabetes mellitus	0.00022	0.00151	CbGpPWpGaD
Pomalidomide—TNF—TGF-beta Receptor Signaling—STAT3—type 1 diabetes mellitus	0.000218	0.0015	CbGpPWpGaD
Pomalidomide—ABCB1—Allograft Rejection—HLA-DPB1—type 1 diabetes mellitus	0.000218	0.00149	CbGpPWpGaD
Pomalidomide—PTGS2—Overview of nanoparticle effects—IL6—type 1 diabetes mellitus	0.000217	0.00149	CbGpPWpGaD
Pomalidomide—TNF—Selenium Micronutrient Network—ALB—type 1 diabetes mellitus	0.000216	0.00148	CbGpPWpGaD
Pomalidomide—TNF—Allograft Rejection—IFNG—type 1 diabetes mellitus	0.000215	0.00148	CbGpPWpGaD
Pomalidomide—ABCB1—Allograft Rejection—HLA-E—type 1 diabetes mellitus	0.000214	0.00147	CbGpPWpGaD
Pomalidomide—TNF—SIDS Susceptibility Pathways—IL10—type 1 diabetes mellitus	0.000212	0.00146	CbGpPWpGaD
Pomalidomide—PTGS2—Spinal Cord Injury—NOS1—type 1 diabetes mellitus	0.000211	0.00145	CbGpPWpGaD
Pomalidomide—TNF—Spinal Cord Injury—CDK4—type 1 diabetes mellitus	0.000209	0.00144	CbGpPWpGaD
Pomalidomide—CYP1A2—Tryptophan metabolism—CAT—type 1 diabetes mellitus	0.000209	0.00143	CbGpPWpGaD
Pomalidomide—PTGS2—Selenium Micronutrient Network—SOD2—type 1 diabetes mellitus	0.000208	0.00143	CbGpPWpGaD
Pomalidomide—TNF—Apoptosis—E2F1—type 1 diabetes mellitus	0.000206	0.00142	CbGpPWpGaD
Pomalidomide—ABCB1—Allograft Rejection—CTLA4—type 1 diabetes mellitus	0.000206	0.00141	CbGpPWpGaD
Pomalidomide—TNF—IL23-mediated signaling events—IL6—type 1 diabetes mellitus	0.000206	0.00141	CbGpPWpGaD
Pomalidomide—TNF—Spinal Cord Injury—NOS2—type 1 diabetes mellitus	0.000203	0.0014	CbGpPWpGaD
Pomalidomide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—type 1 diabetes mellitus	0.000199	0.00137	CbGpPWpGaD
Pomalidomide—TNF—Apoptosis—FASLG—type 1 diabetes mellitus	0.000198	0.00136	CbGpPWpGaD
Pomalidomide—TNF—Selenium Micronutrient Network—IFNG—type 1 diabetes mellitus	0.000197	0.00135	CbGpPWpGaD
Pomalidomide—TNF—Alzheimers Disease—IL1B—type 1 diabetes mellitus	0.000192	0.00132	CbGpPWpGaD
Pomalidomide—TNF—Allograft Rejection—IL1B—type 1 diabetes mellitus	0.000192	0.00132	CbGpPWpGaD
Pomalidomide—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IFNG—type 1 diabetes mellitus	0.000192	0.00132	CbGpPWpGaD
Pomalidomide—TNF—Alzheimers Disease—CASP3—type 1 diabetes mellitus	0.000191	0.00131	CbGpPWpGaD
Pomalidomide—TNF—Allograft Rejection—CASP3—type 1 diabetes mellitus	0.000191	0.00131	CbGpPWpGaD
Pomalidomide—PTGS2—Spinal Cord Injury—CXCL10—type 1 diabetes mellitus	0.000191	0.00131	CbGpPWpGaD
Pomalidomide—TNF—Allograft Rejection—IL2—type 1 diabetes mellitus	0.000191	0.00131	CbGpPWpGaD
Pomalidomide—CYP1A2—Aryl Hydrocarbon Receptor—E2F1—type 1 diabetes mellitus	0.000191	0.00131	CbGpPWpGaD
Pomalidomide—TNF—TWEAK Signaling Pathway—IL6—type 1 diabetes mellitus	0.000186	0.00128	CbGpPWpGaD
Pomalidomide—TNF—MAPK Signaling Pathway—FASLG—type 1 diabetes mellitus	0.000186	0.00128	CbGpPWpGaD
Pomalidomide—CYP1A2—Phase II conjugation—GSTT1—type 1 diabetes mellitus	0.000184	0.00126	CbGpPWpGaD
Pomalidomide—TNF—Apoptosis—CASP3—type 1 diabetes mellitus	0.000182	0.00125	CbGpPWpGaD
Pomalidomide—ABCB1—Allograft Rejection—HLA-DQA1—type 1 diabetes mellitus	0.000182	0.00125	CbGpPWpGaD
Pomalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—IAPP—type 1 diabetes mellitus	0.000178	0.00122	CbGpPWpGaD
Pomalidomide—TNF—Signaling events mediated by HDAC Class I—STAT3—type 1 diabetes mellitus	0.000177	0.00122	CbGpPWpGaD
Pomalidomide—TNF—Selenium Micronutrient Network—IL1B—type 1 diabetes mellitus	0.000176	0.00121	CbGpPWpGaD
Pomalidomide—TNF—Integrated Pancreatic Cancer Pathway—E2F1—type 1 diabetes mellitus	0.000175	0.0012	CbGpPWpGaD
Pomalidomide—PTGS2—Selenium Micronutrient Network—CRP—type 1 diabetes mellitus	0.000174	0.0012	CbGpPWpGaD
Pomalidomide—TNF—Regulation of toll-like receptor signaling pathway—CD80—type 1 diabetes mellitus	0.000173	0.00119	CbGpPWpGaD
Pomalidomide—TNF—Adipogenesis—INS—type 1 diabetes mellitus	0.000173	0.00118	CbGpPWpGaD
Pomalidomide—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CASP3—type 1 diabetes mellitus	0.000171	0.00117	CbGpPWpGaD
Pomalidomide—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2—type 1 diabetes mellitus	0.00017	0.00117	CbGpPWpGaD
Pomalidomide—ABCB1—Allograft Rejection—HLA-DQB1—type 1 diabetes mellitus	0.00017	0.00116	CbGpPWpGaD
Pomalidomide—TNF—TNF alpha Signaling Pathway—CASP3—type 1 diabetes mellitus	0.000169	0.00116	CbGpPWpGaD
Pomalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—IL1R1—type 1 diabetes mellitus	0.000168	0.00115	CbGpPWpGaD
Pomalidomide—TNF—Integrated Pancreatic Cancer Pathway—FASLG—type 1 diabetes mellitus	0.000168	0.00115	CbGpPWpGaD
Pomalidomide—TNF—Adipogenesis—IGF1—type 1 diabetes mellitus	0.000167	0.00114	CbGpPWpGaD
Pomalidomide—ABCB1—Allograft Rejection—CD86—type 1 diabetes mellitus	0.000164	0.00112	CbGpPWpGaD
Pomalidomide—CYP3A4—Tryptophan metabolism—CAT—type 1 diabetes mellitus	0.000161	0.00111	CbGpPWpGaD
Pomalidomide—ABCB1—Allograft Rejection—IL10—type 1 diabetes mellitus	0.00016	0.0011	CbGpPWpGaD
Pomalidomide—ABCB1—Allograft Rejection—CD40LG—type 1 diabetes mellitus	0.00016	0.0011	CbGpPWpGaD
Pomalidomide—PTGS2—Spinal Cord Injury—IL4—type 1 diabetes mellitus	0.00016	0.00109	CbGpPWpGaD
Pomalidomide—TNF—Vitamin B12 Metabolism—IL6—type 1 diabetes mellitus	0.000159	0.00109	CbGpPWpGaD
Pomalidomide—PTGS2—Spinal Cord Injury—E2F1—type 1 diabetes mellitus	0.000159	0.00109	CbGpPWpGaD
Pomalidomide—TNF—Toll-like Receptor Signaling Pathway—IL1B—type 1 diabetes mellitus	0.000156	0.00107	CbGpPWpGaD
Pomalidomide—TNF—Spinal Cord Injury—IFNG—type 1 diabetes mellitus	0.000156	0.00107	CbGpPWpGaD
Pomalidomide—ABCB1—Allograft Rejection—IL4—type 1 diabetes mellitus	0.000156	0.00107	CbGpPWpGaD
Pomalidomide—ABCB1—Transmembrane transport of small molecules—SLC29A3—type 1 diabetes mellitus	0.000153	0.00105	CbGpPWpGaD
Pomalidomide—TNF—MicroRNAs in cardiomyocyte hypertrophy—STAT3—type 1 diabetes mellitus	0.000153	0.00105	CbGpPWpGaD
Pomalidomide—ABCB1—Allograft Rejection—HLA-B—type 1 diabetes mellitus	0.000153	0.00105	CbGpPWpGaD
Pomalidomide—ABCB1—Allograft Rejection—FASLG—type 1 diabetes mellitus	0.000149	0.00102	CbGpPWpGaD
Pomalidomide—PTGS2—Selenium Micronutrient Network—INS—type 1 diabetes mellitus	0.000146	0.001	CbGpPWpGaD
Pomalidomide—ABCB1—Allograft Rejection—IL2RA—type 1 diabetes mellitus	0.000143	0.00098	CbGpPWpGaD
Pomalidomide—TNF—Integrated Pancreatic Cancer Pathway—CDK4—type 1 diabetes mellitus	0.000142	0.000976	CbGpPWpGaD
Pomalidomide—ABCB1—HIF-1-alpha transcription factor network—NOS2—type 1 diabetes mellitus	0.000142	0.000974	CbGpPWpGaD
Pomalidomide—ABCB1—Allograft Rejection—HLA-A—type 1 diabetes mellitus	0.000141	0.000969	CbGpPWpGaD
Pomalidomide—PTGS2—Aryl Hydrocarbon Receptor—EGFR—type 1 diabetes mellitus	0.000139	0.000956	CbGpPWpGaD
Pomalidomide—TNF—Spinal Cord Injury—IL1B—type 1 diabetes mellitus	0.000139	0.000954	CbGpPWpGaD
Pomalidomide—TNF—Spinal Cord Injury—CASP3—type 1 diabetes mellitus	0.000139	0.000952	CbGpPWpGaD
Pomalidomide—TNF—Spinal Cord Injury—IL2—type 1 diabetes mellitus	0.000139	0.000951	CbGpPWpGaD
Pomalidomide—TNF—Developmental Biology—IAPP—type 1 diabetes mellitus	0.000135	0.000925	CbGpPWpGaD
Pomalidomide—PTGS2—Selenium Micronutrient Network—ALB—type 1 diabetes mellitus	0.000134	0.000917	CbGpPWpGaD
Pomalidomide—PTGS2—Aryl Hydrocarbon Receptor—TNF—type 1 diabetes mellitus	0.000133	0.00091	CbGpPWpGaD
Pomalidomide—TNF—Folate Metabolism—IL6—type 1 diabetes mellitus	0.00013	0.00089	CbGpPWpGaD
Pomalidomide—PTGS2—Spinal Cord Injury—CDK4—type 1 diabetes mellitus	0.000129	0.000888	CbGpPWpGaD
Pomalidomide—ABCB1—Allograft Rejection—HLA-DRB1—type 1 diabetes mellitus	0.000129	0.000885	CbGpPWpGaD
Pomalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—IAPP—type 1 diabetes mellitus	0.000126	0.000868	CbGpPWpGaD
Pomalidomide—PTGS2—Spinal Cord Injury—NOS2—type 1 diabetes mellitus	0.000126	0.000863	CbGpPWpGaD
Pomalidomide—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—type 1 diabetes mellitus	0.000124	0.000851	CbGpPWpGaD
Pomalidomide—TNF—Integrated Pancreatic Cancer Pathway—IGF1—type 1 diabetes mellitus	0.000123	0.000842	CbGpPWpGaD
Pomalidomide—PTGS2—C-MYB transcription factor network—CD4—type 1 diabetes mellitus	0.000122	0.000839	CbGpPWpGaD
Pomalidomide—TNF—Regulation of toll-like receptor signaling pathway—IL1B—type 1 diabetes mellitus	0.000122	0.000837	CbGpPWpGaD
Pomalidomide—PTGS2—Selenium Micronutrient Network—IFNG—type 1 diabetes mellitus	0.000122	0.000837	CbGpPWpGaD
Pomalidomide—ABCB1—Allograft Rejection—CD80—type 1 diabetes mellitus	0.000119	0.000818	CbGpPWpGaD
Pomalidomide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—type 1 diabetes mellitus	0.000116	0.000796	CbGpPWpGaD
Pomalidomide—TNF—Apoptosis—CASP3—type 1 diabetes mellitus	0.000112	0.000766	CbGpPWpGaD
Pomalidomide—TNF—SIDS Susceptibility Pathways—IL1B—type 1 diabetes mellitus	0.000111	0.000763	CbGpPWpGaD
Pomalidomide—TNF—SIDS Susceptibility Pathways—CASP3—type 1 diabetes mellitus	0.000111	0.000762	CbGpPWpGaD
Pomalidomide—PTGS2—Selenium Micronutrient Network—IL1B—type 1 diabetes mellitus	0.000109	0.000746	CbGpPWpGaD
Pomalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—E2F1—type 1 diabetes mellitus	0.000108	0.000741	CbGpPWpGaD
Pomalidomide—TNF—Adipogenesis—STAT3—type 1 diabetes mellitus	0.000108	0.00074	CbGpPWpGaD
Pomalidomide—CYP1A2—Biological oxidations—GSTT1—type 1 diabetes mellitus	0.000108	0.00074	CbGpPWpGaD
Pomalidomide—TNF—Spinal Cord Injury—EGFR—type 1 diabetes mellitus	0.000106	0.000727	CbGpPWpGaD
Pomalidomide—TNF—MAPK Signaling Pathway—IL1B—type 1 diabetes mellitus	0.000105	0.000719	CbGpPWpGaD
Pomalidomide—TNF—MAPK Signaling Pathway—CASP3—type 1 diabetes mellitus	0.000105	0.000718	CbGpPWpGaD
Pomalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—FASLG—type 1 diabetes mellitus	0.000104	0.000712	CbGpPWpGaD
Pomalidomide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—type 1 diabetes mellitus	0.000103	0.00071	CbGpPWpGaD
Pomalidomide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—type 1 diabetes mellitus	0.000103	0.000707	CbGpPWpGaD
Pomalidomide—TNF—Selenium Micronutrient Network—IL6—type 1 diabetes mellitus	0.000103	0.000707	CbGpPWpGaD
Pomalidomide—TNF—Developmental Biology—PRKCQ—type 1 diabetes mellitus	0.000102	0.000697	CbGpPWpGaD
Pomalidomide—TNF—TNF alpha Signaling Pathway—IL6—type 1 diabetes mellitus	9.94e-05	0.000682	CbGpPWpGaD
Pomalidomide—PTGS2—Spinal Cord Injury—IFNG—type 1 diabetes mellitus	9.65e-05	0.000662	CbGpPWpGaD
Pomalidomide—TNF—Integrated Pancreatic Cancer Pathway—CASP3—type 1 diabetes mellitus	9.45e-05	0.000648	CbGpPWpGaD
Pomalidomide—ABCB1—Allograft Rejection—IFNG—type 1 diabetes mellitus	9.43e-05	0.000647	CbGpPWpGaD
Pomalidomide—ABCB1—Transmembrane transport of small molecules—G6PC2—type 1 diabetes mellitus	9.28e-05	0.000637	CbGpPWpGaD
Pomalidomide—TNF—Toll-like Receptor Signaling Pathway—IL6—type 1 diabetes mellitus	9.16e-05	0.000628	CbGpPWpGaD
Pomalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—CDK4—type 1 diabetes mellitus	8.81e-05	0.000604	CbGpPWpGaD
Pomalidomide—PTGS2—Spinal Cord Injury—IL1B—type 1 diabetes mellitus	8.61e-05	0.00059	CbGpPWpGaD
Pomalidomide—PTGS2—Spinal Cord Injury—CASP3—type 1 diabetes mellitus	8.59e-05	0.000589	CbGpPWpGaD
Pomalidomide—PTGS2—Spinal Cord Injury—IL2—type 1 diabetes mellitus	8.57e-05	0.000588	CbGpPWpGaD
Pomalidomide—ABCB1—Allograft Rejection—IL1B—type 1 diabetes mellitus	8.41e-05	0.000577	CbGpPWpGaD
Pomalidomide—ABCB1—Allograft Rejection—CASP3—type 1 diabetes mellitus	8.39e-05	0.000576	CbGpPWpGaD
Pomalidomide—ABCB1—Allograft Rejection—IL2—type 1 diabetes mellitus	8.38e-05	0.000575	CbGpPWpGaD
Pomalidomide—CYP3A4—Biological oxidations—GSTT1—type 1 diabetes mellitus	8.32e-05	0.000571	CbGpPWpGaD
Pomalidomide—TNF—Spinal Cord Injury—IL6—type 1 diabetes mellitus	8.15e-05	0.000559	CbGpPWpGaD
Pomalidomide—ABCB1—Transmembrane transport of small molecules—ABCC8—type 1 diabetes mellitus	8.05e-05	0.000552	CbGpPWpGaD
Pomalidomide—TNF—MAPK Signaling Pathway—EGFR—type 1 diabetes mellitus	7.99e-05	0.000548	CbGpPWpGaD
Pomalidomide—PTGS2—Selenium Micronutrient Network—TNF—type 1 diabetes mellitus	7.9e-05	0.000542	CbGpPWpGaD
Pomalidomide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—type 1 diabetes mellitus	7.89e-05	0.000541	CbGpPWpGaD
Pomalidomide—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—type 1 diabetes mellitus	7.89e-05	0.000541	CbGpPWpGaD
Pomalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—E2F1—type 1 diabetes mellitus	7.66e-05	0.000525	CbGpPWpGaD
Pomalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—IGF1—type 1 diabetes mellitus	7.59e-05	0.000521	CbGpPWpGaD
Pomalidomide—TNF—Adipogenesis—IL6—type 1 diabetes mellitus	7.54e-05	0.000517	CbGpPWpGaD
Pomalidomide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—type 1 diabetes mellitus	7.51e-05	0.000515	CbGpPWpGaD
Pomalidomide—CYP1A2—Aryl Hydrocarbon Receptor—TNF—type 1 diabetes mellitus	7.51e-05	0.000515	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism of lipids and lipoproteins—APOC3—type 1 diabetes mellitus	7.45e-05	0.000511	CbGpPWpGaD
Pomalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—type 1 diabetes mellitus	7.36e-05	0.000505	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—G6PC2—type 1 diabetes mellitus	7.32e-05	0.000502	CbGpPWpGaD
Pomalidomide—TNF—Integrated Pancreatic Cancer Pathway—EGFR—type 1 diabetes mellitus	7.21e-05	0.000495	CbGpPWpGaD
Pomalidomide—TNF—Regulation of toll-like receptor signaling pathway—IL6—type 1 diabetes mellitus	7.15e-05	0.00049	CbGpPWpGaD
Pomalidomide—TNF—Developmental Biology—CDK4—type 1 diabetes mellitus	6.66e-05	0.000457	CbGpPWpGaD
Pomalidomide—PTGS2—Spinal Cord Injury—EGFR—type 1 diabetes mellitus	6.56e-05	0.00045	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—HBA2—type 1 diabetes mellitus	6.52e-05	0.000447	CbGpPWpGaD
Pomalidomide—TNF—SIDS Susceptibility Pathways—IL6—type 1 diabetes mellitus	6.52e-05	0.000447	CbGpPWpGaD
Pomalidomide—PTGS2—Selenium Micronutrient Network—IL6—type 1 diabetes mellitus	6.37e-05	0.000437	CbGpPWpGaD
Pomalidomide—PTGS2—Spinal Cord Injury—TNF—type 1 diabetes mellitus	6.25e-05	0.000428	CbGpPWpGaD
Pomalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—type 1 diabetes mellitus	6.24e-05	0.000428	CbGpPWpGaD
Pomalidomide—ABCB1—Transmembrane transport of small molecules—SLC18A2—type 1 diabetes mellitus	6.16e-05	0.000423	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—G6PC2—type 1 diabetes mellitus	6.13e-05	0.000421	CbGpPWpGaD
Pomalidomide—ABCB1—Allograft Rejection—TNF—type 1 diabetes mellitus	6.1e-05	0.000419	CbGpPWpGaD
Pomalidomide—TNF—Developmental Biology—INS—type 1 diabetes mellitus	5.93e-05	0.000407	CbGpPWpGaD
Pomalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—CASP3—type 1 diabetes mellitus	5.84e-05	0.000401	CbGpPWpGaD
Pomalidomide—ABCB1—Transmembrane transport of small molecules—CP—type 1 diabetes mellitus	5.67e-05	0.000389	CbGpPWpGaD
Pomalidomide—ABCB1—Transmembrane transport of small molecules—SLC11A1—type 1 diabetes mellitus	5.62e-05	0.000386	CbGpPWpGaD
Pomalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—type 1 diabetes mellitus	5.38e-05	0.000369	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—ABCC8—type 1 diabetes mellitus	5.32e-05	0.000365	CbGpPWpGaD
Pomalidomide—TNF—Developmental Biology—TYK2—type 1 diabetes mellitus	5.3e-05	0.000363	CbGpPWpGaD
Pomalidomide—PTGS2—Spinal Cord Injury—IL6—type 1 diabetes mellitus	5.04e-05	0.000346	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—HBA2—type 1 diabetes mellitus	4.62e-05	0.000317	CbGpPWpGaD
Pomalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—type 1 diabetes mellitus	4.46e-05	0.000306	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—SLC11A1—type 1 diabetes mellitus	4.44e-05	0.000304	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—G6PC2—type 1 diabetes mellitus	4.35e-05	0.000298	CbGpPWpGaD
Pomalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—type 1 diabetes mellitus	4.25e-05	0.000291	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—ITPR3—type 1 diabetes mellitus	4.24e-05	0.000291	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism of lipids and lipoproteins—APOC3—type 1 diabetes mellitus	4.22e-05	0.000289	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—KCNJ11—type 1 diabetes mellitus	4.2e-05	0.000288	CbGpPWpGaD
Pomalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—type 1 diabetes mellitus	4.14e-05	0.000284	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—APOC3—type 1 diabetes mellitus	3.96e-05	0.000272	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—IAPP—type 1 diabetes mellitus	3.96e-05	0.000272	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—B2M—type 1 diabetes mellitus	3.8e-05	0.000261	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—ABCC8—type 1 diabetes mellitus	3.77e-05	0.000259	CbGpPWpGaD
Pomalidomide—TNF—Developmental Biology—STAT3—type 1 diabetes mellitus	3.71e-05	0.000255	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—HBA2—type 1 diabetes mellitus	3.69e-05	0.000253	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—ITPR3—type 1 diabetes mellitus	3.55e-05	0.000243	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—G6PC2—type 1 diabetes mellitus	3.47e-05	0.000238	CbGpPWpGaD
Pomalidomide—TNF—Developmental Biology—EGFR—type 1 diabetes mellitus	3.37e-05	0.000231	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—HBA1—type 1 diabetes mellitus	3.34e-05	0.000229	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—APOC3—type 1 diabetes mellitus	3.32e-05	0.000228	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—GSTT1—type 1 diabetes mellitus	3.26e-05	0.000224	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—NOS1—type 1 diabetes mellitus	3.19e-05	0.000219	CbGpPWpGaD
Pomalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—type 1 diabetes mellitus	3.16e-05	0.000217	CbGpPWpGaD
Pomalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—type 1 diabetes mellitus	3.01e-05	0.000207	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—ABCC8—type 1 diabetes mellitus	3.01e-05	0.000206	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism of lipids and lipoproteins—ALB—type 1 diabetes mellitus	3e-05	0.000206	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—PRKCQ—type 1 diabetes mellitus	2.98e-05	0.000205	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—KCNJ11—type 1 diabetes mellitus	2.98e-05	0.000204	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—VAV1—type 1 diabetes mellitus	2.9e-05	0.000199	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—HBA2—type 1 diabetes mellitus	2.85e-05	0.000195	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—G6PC2—type 1 diabetes mellitus	2.68e-05	0.000184	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—GCG—type 1 diabetes mellitus	2.6e-05	0.000178	CbGpPWpGaD
Pomalidomide—TNF—Developmental Biology—IL6—type 1 diabetes mellitus	2.59e-05	0.000178	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—CD86—type 1 diabetes mellitus	2.53e-05	0.000173	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—ITPR3—type 1 diabetes mellitus	2.51e-05	0.000172	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—KCNJ11—type 1 diabetes mellitus	2.38e-05	0.000163	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—HBA1—type 1 diabetes mellitus	2.37e-05	0.000162	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—APOC3—type 1 diabetes mellitus	2.35e-05	0.000161	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—ABCC8—type 1 diabetes mellitus	2.32e-05	0.000159	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—GSTT1—type 1 diabetes mellitus	2.31e-05	0.000158	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—ERBB3—type 1 diabetes mellitus	2.28e-05	0.000156	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—CCR5—type 1 diabetes mellitus	2.24e-05	0.000154	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—CAT—type 1 diabetes mellitus	2.2e-05	0.000151	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—HLA-A—type 1 diabetes mellitus	2.18e-05	0.00015	CbGpPWpGaD
Pomalidomide—ABCB1—Transmembrane transport of small molecules—ALB—type 1 diabetes mellitus	2.02e-05	0.000139	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—ITPR3—type 1 diabetes mellitus	2.01e-05	0.000138	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—NOS2—type 1 diabetes mellitus	1.9e-05	0.00013	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—HBA1—type 1 diabetes mellitus	1.89e-05	0.00013	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—APOC3—type 1 diabetes mellitus	1.88e-05	0.000129	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—GSTT1—type 1 diabetes mellitus	1.84e-05	0.000126	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—CD80—type 1 diabetes mellitus	1.84e-05	0.000126	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—GCG—type 1 diabetes mellitus	1.84e-05	0.000126	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—KCNJ11—type 1 diabetes mellitus	1.84e-05	0.000126	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—INS—type 1 diabetes mellitus	1.74e-05	0.000119	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism of lipids and lipoproteins—ALB—type 1 diabetes mellitus	1.7e-05	0.000117	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—CAT—type 1 diabetes mellitus	1.56e-05	0.000107	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—TYK2—type 1 diabetes mellitus	1.56e-05	0.000107	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—ITPR3—type 1 diabetes mellitus	1.55e-05	0.000106	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—NOS3—type 1 diabetes mellitus	1.53e-05	0.000105	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—GCG—type 1 diabetes mellitus	1.47e-05	0.000101	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—INS—type 1 diabetes mellitus	1.46e-05	0.0001	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—HBA1—type 1 diabetes mellitus	1.46e-05	0.0001	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—APOC3—type 1 diabetes mellitus	1.45e-05	9.94e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—GSTT1—type 1 diabetes mellitus	1.42e-05	9.76e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—CD4—type 1 diabetes mellitus	1.41e-05	9.65e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—ALB—type 1 diabetes mellitus	1.34e-05	9.17e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—NOS3—type 1 diabetes mellitus	1.28e-05	8.78e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—CAT—type 1 diabetes mellitus	1.24e-05	8.53e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—GCG—type 1 diabetes mellitus	1.13e-05	7.78e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—STAT3—type 1 diabetes mellitus	1.09e-05	7.48e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—INS—type 1 diabetes mellitus	1.03e-05	7.09e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—EGFR—type 1 diabetes mellitus	9.91e-06	6.79e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—CAT—type 1 diabetes mellitus	9.6e-06	6.58e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—ALB—type 1 diabetes mellitus	9.48e-06	6.5e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—NOS3—type 1 diabetes mellitus	9.07e-06	6.22e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—INS—type 1 diabetes mellitus	8.26e-06	5.66e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—IL6—type 1 diabetes mellitus	7.61e-06	5.22e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—ALB—type 1 diabetes mellitus	7.57e-06	5.19e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—NOS3—type 1 diabetes mellitus	7.24e-06	4.97e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—INS—type 1 diabetes mellitus	6.37e-06	4.37e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—ALB—type 1 diabetes mellitus	5.84e-06	4.01e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—NOS3—type 1 diabetes mellitus	5.59e-06	3.83e-05	CbGpPWpGaD
